{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T18:12:01Z","timestamp":1771956721384,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP20wm0325012"],"award-info":[{"award-number":["JP20wm0325012"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP21wm0325042"],"award-info":[{"award-number":["JP21wm0325042"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["19K07580"],"award-info":[{"award-number":["19K07580"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["19K22560"],"award-info":[{"award-number":["19K22560"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["20H03493"],"award-info":[{"award-number":["20H03493"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.virol.2022.01.006","type":"journal-article","created":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T08:13:26Z","timestamp":1642666406000},"page":"31-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["PD-L1 upregulation by lytic induction of Epstein-Barr Virus"],"prefix":"10.1016","volume":"568","author":[{"given":"Yusuke","family":"Yanagi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuya","family":"Hara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiyo","family":"Mabuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8541-6413","authenticated-orcid":false,"given":"Yoshitaka","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7228-0839","authenticated-orcid":false,"given":"Takayuki","family":"Murata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.virol.2022.01.006_bib1","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1073\/pnas.89.3.905","article-title":"Host-cell-phenotype-dependent control of the BCR2\/BWR1 promoter complex regulates the expression of Epstein-Barr virus nuclear antigens 2-6","volume":"89","author":"Altiok","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.virol.2022.01.006_bib2","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41375-018-0178-x","article-title":"Epstein-Barr virus-encoded EBNA2 alters immune checkpoint PD-L1 expression by downregulating miR-34a in B-cell lymphomas","volume":"33","author":"Anastasiadou","year":"2019","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.virol.2022.01.006_bib3","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1038\/cti.2015.1","article-title":"Infectious mononucleosis","volume":"4","author":"Balfour","year":"2015","journal-title":"Clin. Transl. Immunol."},{"issue":"1","key":"10.1016\/j.virol.2022.01.006_bib4","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s13045-016-0341-7","article-title":"PD-L1 is upregulated by EBV-driven LMP1 through NF-kappaB pathway and correlates with poor prognosis in natural killer\/T-cell lymphoma","volume":"9","author":"Bi","year":"2016","journal-title":"J. Hematol. Oncol."},{"issue":"15","key":"10.1016\/j.virol.2022.01.006_bib5","doi-asserted-by":"crossref","first-page":"8532","DOI":"10.1128\/JVI.77.15.8532-8540.2003","article-title":"NF-kappaB inhibits gammaherpesvirus lytic replication","volume":"77","author":"Brown","year":"2003","journal-title":"J. Virol."},{"issue":"7517","key":"10.1016\/j.virol.2022.01.006_bib6","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nature13480","article-title":"Comprehensive molecular characterization of gastric adenocarcinoma","volume":"513","author":"Cancer Genome Atlas Research","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.virol.2022.01.006_bib7","first-page":"75","article-title":"Role of PD-1 in immunity and diseases","volume":"410","author":"Chamoto","year":"2017","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.virol.2022.01.006_bib8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.virol.2019.07.024","article-title":"Expression of PD-1 and PD-Ls in Kaposi's sarcoma and regulation by oncogenic herpesvirus lytic reactivation","volume":"536","author":"Chen","year":"2019","journal-title":"Virology"},{"issue":"7","key":"10.1016\/j.virol.2022.01.006_bib9","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJM200008173430707","article-title":"Epstein-Barr virus infection","volume":"343","author":"Cohen","year":"2000","journal-title":"N. Engl. J. Med."},{"issue":"23","key":"10.1016\/j.virol.2022.01.006_bib10","doi-asserted-by":"crossref","first-page":"12189","DOI":"10.18632\/oncotarget.2608","article-title":"EBV-driven LMP1 and IFN-gamma up-regulate PD-L1 in nasopharyngeal carcinoma: implications for oncotargeted therapy","volume":"5","author":"Fang","year":"2014","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.virol.2022.01.006_bib11","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1128\/JVI.78.4.1893-1902.2004","article-title":"Lytic induction therapy for Epstein-Barr virus-positive B-cell lymphomas","volume":"78","author":"Feng","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2022.01.006_bib12","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.coviro.2018.08.012","article-title":"Epigenetic crossroads of the Epstein-Barr virus B-cell relationship","volume":"32","author":"Frost","year":"2018","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.virol.2022.01.006_bib13","doi-asserted-by":"crossref","first-page":"104368","DOI":"10.1016\/j.meegid.2020.104368","article-title":"The roles of programmed death ligand 1 in virus-associated cancers","volume":"84","author":"Golrokh Mofrad","year":"2020","journal-title":"Infect. Genet. Evol."},{"issue":"6","key":"10.1016\/j.virol.2022.01.006_bib14","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1158\/1078-0432.CCR-11-1942","article-title":"Constitutive AP-1 activity and EBV infection induce PD-L1 in Hodgkin lymphomas and posttransplant lymphoproliferative disorders: implications for targeted therapy","volume":"18","author":"Green","year":"2012","journal-title":"Clin. Cancer Res."},{"issue":"Pt 7","key":"10.1016\/j.virol.2022.01.006_bib15","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1099\/0022-1317-71-7-1481","article-title":"Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line","volume":"71","author":"Gregory","year":"1990","journal-title":"J. Gen. Virol."},{"issue":"1","key":"10.1016\/j.virol.2022.01.006_bib16","doi-asserted-by":"crossref","first-page":"a013029","DOI":"10.1101\/cshperspect.a013029","article-title":"Replication of epstein-barr viral DNA","volume":"5","author":"Hammerschmidt","year":"2013","journal-title":"Cold Spring Harbor Perspect. Biol."},{"issue":"1","key":"10.1016\/j.virol.2022.01.006_bib17","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3181\/00379727-124-31677","article-title":"Cloning of immunoglobulin-producing human leukemic and lymphoma cells in long-term cultures","volume":"124","author":"Hinuma","year":"1967","journal-title":"Proc Soc Exp Biol Med"},{"issue":"1","key":"10.1016\/j.virol.2022.01.006_bib18","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12943-018-0928-4","article-title":"Role of the tumor microenvironment in PD-L1\/PD-1-mediated tumor immune escape","volume":"18","author":"Jiang","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.virol.2022.01.006_bib19","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/978-981-10-7230-7_17","article-title":"EBV-encoded latent genes","volume":"1045","author":"Kanda","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"issue":"3","key":"10.1016\/j.virol.2022.01.006_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms9030603","article-title":"Epstein-barr virus LMP1 induces soluble PD-L1 in nasopharyngeal carcinoma","volume":"9","author":"Kase","year":"2021","journal-title":"Microorganisms"},{"issue":"7","key":"10.1016\/j.virol.2022.01.006_bib21","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1038\/s41375-019-0380-5","article-title":"Frequent structural variations involving programmed death ligands in Epstein-Barr virus-associated lymphomas","volume":"33","author":"Kataoka","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.virol.2022.01.006_bib22","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.semcancer.2014.01.002","article-title":"Regulation of the latent-lytic switch in Epstein-Barr virus","volume":"26","author":"Kenney","year":"2014","journal-title":"Semin. Cancer Biol."},{"issue":"3","key":"10.1016\/j.virol.2022.01.006_bib23","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1128\/jvi.43.3.979-986.1982","article-title":"Epstein-Barr virus DNA XII. A variable region of the Epstein-Barr virus genome is included in the P3HR-1 deletion","volume":"43","author":"King","year":"1982","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2022.01.006_bib24","doi-asserted-by":"crossref","first-page":"107553","DOI":"10.1016\/j.intimp.2021.107553","article-title":"Expression of PD-L1 in EBV-associated malignancies","volume":"95","author":"Li","year":"2021","journal-title":"Int. Immunopharm."},{"issue":"7","key":"10.1016\/j.virol.2022.01.006_bib25","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1111\/cas.13634","article-title":"Therapies based on targeting Epstein-Barr virus lytic replication for EBV-associated malignancies","volume":"109","author":"Li","year":"2018","journal-title":"Cancer Sci."},{"key":"10.1016\/j.virol.2022.01.006_bib26","first-page":"237","article-title":"Epstein-barr virus lytic cycle reactivation","volume":"391","author":"McKenzie","year":"2015","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"6","key":"10.1016\/j.virol.2022.01.006_bib27","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/1348-0421.12155","article-title":"Regulation of Epstein-Barr virus reactivation from latency","volume":"58","author":"Murata","year":"2014","journal-title":"Microbiol. Immunol."},{"issue":"4","key":"10.1016\/j.virol.2022.01.006_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms9040778","article-title":"Human herpesvirus and the immune checkpoint PD-1\/PD-L1 pathway: disorders and strategies for survival","volume":"9","author":"Murata","year":"2021","journal-title":"Microorganisms"},{"issue":"12","key":"10.1016\/j.virol.2022.01.006_bib29","doi-asserted-by":"crossref","first-page":"8033","DOI":"10.1074\/jbc.M808466200","article-title":"TORC2, a coactivator of cAMP-response element-binding protein, promotes Epstein-Barr virus reactivation from latency through interaction with viral BZLF1 protein","volume":"284","author":"Murata","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.virol.2022.01.006_bib30","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/rmv.1786","article-title":"Modes of infection and oncogenesis by the Epstein-Barr virus","volume":"24","author":"Murata","year":"2014","journal-title":"Rev. Med. Virol."},{"issue":"7","key":"10.1016\/j.virol.2022.01.006_bib31","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s00262-017-1987-x","article-title":"Programmed death-ligand 1 and its soluble form are highly expressed in nasal natural killer\/T-cell lymphoma: a potential rationale for immunotherapy","volume":"66","author":"Nagato","year":"2017","journal-title":"Cancer Immunol. Immunother."},{"issue":"3","key":"10.1016\/j.virol.2022.01.006_bib32","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41564-018-0334-0","article-title":"Defective Epstein-Barr virus in chronic active infection and haematological malignancy","volume":"4","author":"Okuno","year":"2019","journal-title":"Nat. Microbiol."},{"issue":"11","key":"10.1016\/j.virol.2022.01.006_bib33","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1517\/14712598.6.11.1193","article-title":"The role of Epstein-Barr virus in cancer","volume":"6","author":"Pattle","year":"2006","journal-title":"Expet Opin. Biol. Ther."},{"issue":"7","key":"10.1016\/j.virol.2022.01.006_bib34","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.1128\/JVI.02020-12","article-title":"Epstein-Barr virus deubiquitinase downregulates TRAF6-mediated NF-kappaB signaling during productive replication","volume":"87","author":"Saito","year":"2013","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.virol.2022.01.006_bib35","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s10120-018-0880-4","article-title":"EBV-associated gastric cancer evades T-cell immunity by PD-1\/PD-L1 interactions","volume":"22","author":"Sasaki","year":"2019","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.virol.2022.01.006_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.4198","article-title":"EBV-positive B-cell lymphomas and lymphoproliferative disorders: review from the perspective of immune escape and immunodeficiency","author":"Satou","year":"2021","journal-title":"Cancer Med"},{"key":"10.1016\/j.virol.2022.01.006_bib37","doi-asserted-by":"crossref","first-page":"713","DOI":"10.3389\/fonc.2019.00713","article-title":"The global landscape of EBV-associated tumors","volume":"9","author":"Shannon-Lowe","year":"2019","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.virol.2022.01.006_bib38","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/rmv.441","article-title":"Latent and lytic Epstein-Barr virus replication strategies","volume":"15","author":"Tsurumi","year":"2005","journal-title":"Rev. Med. Virol."},{"issue":"7","key":"10.1016\/j.virol.2022.01.006_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27757","article-title":"PD-L1 expression in pediatric Epstein-Barr virus positive classic Hodgkin lymphoma is not associated with 9p24.1 amplification","volume":"66","author":"Uccini","year":"2019","journal-title":"Pediatr. Blood Cancer"},{"issue":"1","key":"10.1016\/j.virol.2022.01.006_bib40","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000511243","article-title":"DNA methylation and genetic aberrations in gastric cancer","volume":"102","author":"Usui","year":"2021","journal-title":"Digestion"},{"issue":"3","key":"10.1016\/j.virol.2022.01.006_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/v11030285","article-title":"Initial characterization of the Epstein(-)Barr virus BSRF1 gene product","volume":"11","author":"Yanagi","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.virol.2022.01.006_bib42","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.virol.2021.02.004","article-title":"RNAseq analysis identifies involvement of EBNA2 in PD-L1 induction during Epstein-Barr virus infection of primary B cells","volume":"557","author":"Yanagi","year":"2021","journal-title":"Virology"},{"issue":"8","key":"10.1016\/j.virol.2022.01.006_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12082142","article-title":"Lytic induction therapy against epstein-barr virus-associated malignancies: past, present, and future","volume":"12","author":"Yiu","year":"2020","journal-title":"Cancers"}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004268222200006X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004268222200006X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:56:22Z","timestamp":1758588982000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004268222200006X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":43,"alternative-id":["S004268222200006X"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2022.01.006","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PD-L1 upregulation by lytic induction of Epstein-Barr Virus","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2022.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}